Follow
Randall N. Hyer
Randall N. Hyer
President, Baruch S. Blumberg Institute
Verified email at post.harvard.edu
Title
Cited by
Cited by
Year
Effective media communication during public health emergencies
R Hyer
WHO Handbook, 2007
101*2007
How New Models Of Vaccine Development For COVID-19 Have Helped Address An Epic Public Health Crisis: Article describes and analyzes how resources, cooperation, and innovation …
DE Bloom, D Cadarette, M Ferranna, RN Hyer, DL Tortorice
Health Affairs 40 (3), 410-418, 2021
772021
Current issues in adolescent immunization
L Brabin, DP Greenberg, L Hessel, R Hyer, B Ivanoff, P Van Damme
Vaccine 26 (33), 4120-4134, 2008
682008
Safety of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant in adults
R Hyer, DK McGuire, B Xing, S Jackson, R Janssen
Vaccine 36 (19), 2604-2611, 2018
582018
Immunogenicity and safety of a 2-dose hepatitis B vaccine, HBsAg/CpG 1018, in persons with diabetes mellitus aged 60–70 years
RN Hyer, RS Janssen
Vaccine 37 (39), 5854-5861, 2019
522019
Implications of recent epidemiologic studies for the linear nonthreshold model and radiation protection
NC No
NCRP, 2018
402018
Cost-effectiveness analysis of reacquiring and using adenovirus types 4 and 7 vaccines in naval recruits.
RN Hyer, MR Howell, MA Ryan, JC Gaydos
The American journal of tropical medicine and hygiene 62 (5), 613-618, 2000
342000
Telemedical experiences at an Antarctic station
RN Hyer
Journal of telemedicine and telecare 5 (1_suppl), 87-89, 1999
341999
Association of number of doses with hepatitis B vaccine series completion in US adults
K Bruxvoort, J Slezak, R Huang, B Ackerson, LS Sy, L Qian, K Reynolds, ...
JAMA network open 3 (11), e2027577-e2027577, 2020
272020
An open-label, single-arm study evaluating the immunogenicity and safety of the hepatitis B vaccine HepB-CpG (HEPLISAV-B®) in adults receiving hemodialysis
AM Awad, A Ntoso, JJ Connaire, GT Hernandez, K Dhillon, L Rich, ...
Vaccine 39 (25), 3346-3352, 2021
232021
Breaking bad news in the high-concern, low trust setting: how to get your story heard
RN Hyer, VT Covello
Health physics 112 (2), 111-115, 2017
232017
Department of defense global emerging infections surveillance and response system Indian Ocean tsunami response
JP Chretien, JS Glass, RC Coldren, DL Noah, RN Hyer, JC Gaydos, ...
Military medicine 171 (suppl_1), 12-14, 2006
202006
Comparative cost-effectiveness of a 2-dose versus 3-dose vaccine for hepatitis B prevention in selected adult populations
A Hirst, RN Hyer, RS Janssen
Vaccine 39 (33), 4733-4741, 2021
142021
Emerging heterologous mRNA-based booster strategies within the COVID-19 vaccine landscape
R Das, RN Hyer, P Burton, JM Miller, BJ Kuter
Human Vaccines & Immunotherapeutics 19 (1), 2153532, 2023
132023
COVID-19: simple answers to top questions, risk communication guide
V Covello, R Hyer
Association of State and Territorial Health Officials, Arlington, Virginia, USA, 2020
132020
Synergies resulting from a systems biology approach: integrating radiation epidemiology and radiobiology to optimize protection of the public after exposure to low doses of …
N Dainiak, LE Feinendegen, RN Hyer, PA Locke, AE Waltar
International journal of radiation biology 94 (1), 2-7, 2018
132018
Considerations for estimating real-world outcomes and value in vaccination: A case study with adult hepatitis B virus vaccination
RS Janssen, K Bruxvoort, SJ Jacobsen, J Slezak, C David, R Hyer, ...
Vaccine 39 (39), 5666-5672, 2021
82021
286. Hepatitis B vaccine compliance: comparing 2-dose and 3-dose vaccines
K Bruxvoort, J Slezak, R Huang, LS Sy, W Towner, B Ackerson, ...
Open Forum Infectious Diseases 6 (Suppl 2), S156, 2019
52019
COVID-19 and the Seven Pillars of Effective Risk and Crisis Communication
VT Covello, RN Hyer
The Business of Pandemics, 71-82, 2020
42020
NCRP program area committee 7: Radiation education, risk communication, outreach, and policy
RN Hyer
Health Physics 114 (2), 259-260, 2018
42018
The system can't perform the operation now. Try again later.
Articles 1–20